A community has come together to surprise 9-year-old Killian Bauer who is living with Duchenne muscular dystrophy, with a ...

She visited Fann hospital in Dakar, where neurologist Dr. Pedro Rodriguez measured her lung capacity. He suspects Mariama had ...

Joe Bowen estimates this is the tenth home he’s renovated in his 82 years, and he says this one in Hazel Green is the most ...

The Remarkable Life of Ibelin, a documentary on Netflix, explains how a terminally ill boy found freedom in World of Warcraft ...

A Shotts mum will head a 45-strong group taking part in this weekend’s Glasgow Kiltwalk to raise money for her four-year-old ...

The EC has granted orphan drug designation to Dyne Therapeutics’ DYNE-251 for treating Duchenne muscular dystrophy (DMD).

Recently presented data demonstrated sustained functional improvement with DYNE-251 treatment through 18 months - - Data from the fully enrolled DELIVER registrational expansion cohort is planned for ...

Duchenne muscular dystrophy (DMD) is a devastating genetic disorder affecting approximately 1 in 3,500-5,000 newborn males worldwide. It is characterized by progressive degeneration of skeletal, ...

Dyne Therapeutics, Inc.’s DYN share price has surged by 9.28%, which has investors questioning if this is right time to sell.